Stock RV6 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Charles River Laboratories International, Inc. Börse Stuttgart

Equities

RV6

US1598641074

Market Closed - Börse Stuttgart
Other stock markets
 09:26:11 31/05/2024 pm IST 		5-day change 1st Jan Change
191.2 EUR -1.24% Intraday chart for Charles River Laboratories International, Inc. -4.11% -10.09%
30/05 Charles River Laboratories International, Inc. Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy Development CI
15/05 Transcript : Charles River Laboratories International, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 10:00 AM

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
TD Cowen Adjusts Price Target on Charles River Laboratories International to $228 From $260
MT
JPMorgan Adjusts Price Target on Charles River Laboratories International to $270 From $280
MT
Jefferies Adjusts Price Target on Charles River Laboratories International to $226 From $235
MT
Evercore ISI Adjusts Price Target on Charles River Laboratories International to $265 From $300
MT
Baird Adjusts Price Target on Charles River Laboratories International to $270 From $282
MT
Zacks Investment Research Adjusts Charles River Laboratories International's Price Target to $259 From $278
MT
Charles River Laboratories Signs Plasmid DNA Manufacturing Deal With Ship of Theseus
MT
Deutsche Bank Raises Price Target on Charles River Laboratories to $300 From $275, Keeps Buy Rating
MT
Argus Raises Price Target on Charles River Laboratories International to $290 From $200, Maintains Buy Rating
MT
Deutsche Bank Raises Charles River Laboratories International Price Target to $275 From $245, Maintains Buy Rating
MT
Morgan Stanley Raises Price Target on Charles River Laboratories International to $235 From $205, Keeps Equalweight Rating
MT
TD Cowen Adjusts Charles River Laboratories International's PT to $260 From $193, Keeps Market Perform Rating
MT
Stephens Adjusts Charles River Laboratories International's PT to $280 From $270, Keeps Overweight Rating
MT
Citigroup Adjusts Price Target on Charles River Laboratories International to $250 From $215, Maintains Neutral Rating
MT
UBS Adjusts Charles River Laboratories International Price Target to $290 From $270, Maintains Buy Rating
MT
JPMorgan Adjusts Price Target on Charles River Laboratories International to $280 From $270, Maintains Overweight Rating
MT
Baird Adjusts Price Target on Charles River Laboratories International to $268 From $252, Maintains Outperform Rating
MT
Guggenheim Downgrades Charles River Laboratories International to Neutral From Buy
MT
Futures climb after Wall St sell-off; rate-cut jitters loom
RE
UBS Adjusts Charles River Laboratories International Price Target to $270 From $215, Maintains Buy Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CRL Stock
  4. RV6 Stock
  5. News Charles River Laboratories International, Inc.
  6. Analyst Reco.